Kamal Gada
Senior Vice President- Equity at UTI
Kamal Gada is named on 3 schemes at UTI. Of the 2 ranked with a three-year record, 3-year CAGR runs from 22.9% (UTI - Healthcare Fund - Direct Plan - Growth) down to 7.3% (UTI - Flexi Cap Fund. - Direct Plan - Growth), across Sectoral/ Thematic, Flexi Cap Fund. Returns are computed from AMFI NAV history and are net of expenses; the roles and dates come from UTI's SEBI filings.
Background
- Qualifications
- B.com, CA, CS, CFA
- Experience
- He is the Vice President - Equity. He completed CA from ICAI and has cleared Level 3 of CFA from CFA Institute, USA. He graduated in Bachelor of Commerce in 2003 from Mumbai University. He began his career with BPCL as Senior Accounts Officer in 2004. Kamal joined UTI AMC in 2008 as Research Analyst. Presently he is Fund Manager for UTI Healthcare Fund as well as covers Pharma and Chemicals sector. He has over 16 years of experience in Equity Research. May 2025
Funds Kamal Gada manages
2Named on 3 schemes; the 2 with a three-year record are ranked by 3Y CAGR. Open a fund for NAV history, rolling returns, risk metrics and peer rank.
| 1 | UTI - Healthcare Fund | ★★★★☆ | +15.5% | +22.9% | +14.9% | 1.34% | ₹1,181Cr |
| 2 | UTI - Flexi Cap Fund. | ★★☆☆☆ | -3.5% | +7.3% | +3.7% | 1.16% | ₹22,328Cr |
NAV data as of 05 Oct 2026. Role, qualifications and tenure are disclosures from UTI’s Scheme Information Documents and Statement of Additional Information — SEBI filings, not our assessment of anyone. Returns are computed from AMFI NAV history; see our methodology. A fund’s performance is not attributable to one person, and nothing here is investment advice.